Literature DB >> 18772607

Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats.

Satomi Higo1, Satoshi Miyata, Qing Yun Jiang, Riko Kitazawa, Sohei Kitazawa, Masato Kasuga.   

Abstract

Oxidative stress has been postulated to be involved in the development of diabetic nephropathy. In the present study, we evaluated the effect of taurine, an endogenous antioxidant, on diabetic nephropathy by mixing it with the daily drinking water (1%w/v) of streptozotocin-induced diabetic rats from the beginning of the fourth month after the induction of diabetes, during which the urinary protein excretion in untreated diabetic rats showed significant increase in comparison with nondiabetic rats. The taurine administration significantly suppressed further increase in urinary protein excretion in diabetic rats, accompanied by the reduction of mesangial extracellular matrix expansion and TGF-beta expression in the renal glomerulus. Immunohistochemical study showed that taurine administration suppressed the intensified stainings to the three different types of oxidative stress markers, such as 8-hydroxyl-2'-deoxyguanosine (8-OHdG), pentosidine, and nitrotyrosine observed in the renal tissues of untreated diabetic rats. These findings suggest that taurine has the ability to suppress the progression of diabetic nephropathy at least in part by its antioxidant property. Since this beneficial effect of taurine was obtained even if its administration was started after the time point when urinary protein excretion already became apparently higher than that of age-matched nondiabetic animals, taurine administration was potentially expected to be applied in clinical field to retard the development of nephropathy in diagnosed diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772607

Source DB:  PubMed          Journal:  Kobe J Med Sci        ISSN: 0023-2513


  6 in total

Review 1.  Ameliorative effects of taurine against diabetes: a review.

Authors:  Fengyuan Piao; Rana Muhammad Aadil; Raheel Suleman; Kaixin Li; Mengren Zhang; Pingan Wu; Muhammad Shahbaz; Zulfiqar Ahmed
Journal:  Amino Acids       Date:  2018-02-28       Impact factor: 3.520

2.  Preventive effect of taurine on experimental type II diabetic nephropathy.

Authors:  Shumei Lin; Jiancheng Yang; Gaofeng Wu; Mei Liu; Xinhong Luan; Qiufeng Lv; He Zhao; Jianmin Hu
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 3.  The potential usefulness of taurine on diabetes mellitus and its complications.

Authors:  Takashi Ito; Stephen W Schaffer; Junichi Azuma
Journal:  Amino Acids       Date:  2011-03-25       Impact factor: 3.520

4.  Analysis of serum metabolomics among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls.

Authors:  Sibei Tao; Wen Zheng; Yuan Liu; Ling Li; Lingzhi Li; Qian Ren; Min Shi; Jing Liu; Jing Jiang; Huichao Ma; Zhuo Huang; Zijing Xia; Jing Pan; Tiantian Wei; Yan Wang; Peiyun Li; Tian Lan; Liang Ma; Ping Fu
Journal:  RSC Adv       Date:  2019-06-26       Impact factor: 3.361

Review 5.  Characteristics of Selected Antioxidative and Bioactive Compounds in Meat and Animal Origin Products.

Authors:  Bartosz Kulczyński; Andrzej Sidor; Anna Gramza-Michałowska
Journal:  Antioxidants (Basel)       Date:  2019-08-22

6.  Taurine alleviates the progression of diabetic nephropathy in type 2 diabetic rat model.

Authors:  Jang Hyun Koh; Eun Soo Lee; Miri Hyun; Hong Min Kim; Yoon Jung Choi; Eun Young Lee; Dhananjay Yadav; Choon Hee Chung
Journal:  Int J Endocrinol       Date:  2014-02-23       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.